|
12 Health Care Stocks Moving In Friday's After-Market Session
|
|
|
bioAffinity Technologies shares are trading higher after the company announced it received a notice of allowance for a U.S. patent titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING"
|
|
|
bioAffinity Technologies Has Received A Notice Of Allowance For A U.S. Patent Titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING".
|
|
|
bioAffinity's CyPath Lung Diagnostic Detects Cancer In Challenging Case, Enabling Immediate Treatment Over Years Of Watchful Waiting
|
|
|
U.S. Medicine Features bioAffinity's CyPath Lung Test For Enhanced VA Lung Cancer Detection And Cost Reduction
|
|